SMAD1 and neoplasm: Since in tumor cells the stimulated TGFb receptor phosphorylates SMAD1/5 and promotes cell migration, it is concluded that the TGFb-TGFBR1-SMAD1/5 axis could be of clinical interest (Chappell et al., 2021).